Accelerate Diagnostics In... (AXDX)
NASDAQ: AXDX
· Real-Time Price · USD
0.03
-0.00 (-11.76%)
At close: May 14, 2025, 3:59 PM
Accelerate Diagnostics Revenue Breakdown
| Period Ending | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 |
|---|---|---|---|---|---|---|---|
| Product and Service, Other Revenue | -33K | 10.61M | 11.11M | 10.43M | 10.34M | 8.84M | 5.58M |
| Product and Service, Other Revenue Growth | -100.31% | -4.48% | +6.49% | +0.91% | +16.94% | +58.52% | n/a |
| Product Revenue | 10.22M | 1.45M | 1.65M | 1.35M | 829K | 458K | 94K |
| Product Revenue Growth | +604.62% | -11.85% | +21.67% | +63.09% | +81.00% | +387.23% | n/a |
| Service Revenue | 1.48M | n/a | n/a | n/a | n/a | n/a | n/a |
| Service Revenue Growth | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expense Breakdown
| Period Ending | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 4.61M | 5.64M | 5.38M | 5.71M | 5.8M | 7.76M | 7.56M | 10.11M | 8.77M | 8.26M | 11.49M | 10.67M | 11.49M | 10.81M | 12.91M | 14.03M | 11.17M | 11.46M | 11.33M | 12.94M | 13.58M | 12.74M | 12.84M | 12.72M | 13.38M | 12.15M | 15.33M | 14.35M | 11.47M | 11.6M | 11.46M | 10.53M | 10.22M | 9.31M | 9.24M | 7.44M | 5.93M | 4.33M | 4.75M | 2.87M |
| Selling, General, and Administrative Revenue Growth | -18.29% | +4.78% | -5.73% | -1.62% | -25.27% | +2.60% | -25.15% | +15.21% | +6.25% | -28.17% | +7.68% | -7.13% | +6.35% | -16.30% | -7.98% | +25.64% | -2.61% | +1.17% | -12.45% | -4.72% | +6.60% | -0.73% | +0.90% | -4.90% | +10.09% | -20.72% | +6.81% | +25.15% | -1.14% | +1.23% | +8.87% | +3.02% | +9.77% | +0.75% | +24.23% | +25.43% | +36.87% | -8.90% | +65.85% | n/a |
| Research and Development Revenue | 3.77M | 3.84M | 3.9M | 5.17M | 5.6M | 7M | 5.82M | 6.97M | 6.03M | 7.29M | 7.58M | 6.02M | 4.6M | 4.71M | 5.73M | 6.89M | 5.06M | 5M | 5.35M | 5.84M | 6.2M | 6.06M | 6.15M | 6.93M | 6.9M | 7.89M | 6.06M | 6.78M | 6.13M | 6.35M | 5.53M | 4.29M | 5.25M | 7.53M | 8.06M | 7.35M | 6.02M | 6.5M | 7.13M | 6.38M |
| Research and Development Revenue Growth | -1.67% | -1.67% | -24.55% | -7.62% | -19.95% | +20.21% | -16.48% | +15.56% | -17.23% | -3.84% | +25.76% | +30.90% | -2.33% | -17.81% | -16.85% | +36.16% | +1.26% | -6.47% | -8.47% | -5.77% | +2.24% | -1.38% | -11.31% | +0.42% | -12.51% | +30.21% | -10.65% | +10.55% | -3.40% | +14.91% | +28.89% | -18.29% | -30.31% | -6.59% | +9.64% | +22.16% | -7.39% | -8.80% | +11.75% | n/a |